Prolonged survival in Churg-Strauss syndrome [2]

Annals of Allergy, Asthma and Immunology

Volumn 92, Issue 1, 2004, Pages 92-93

  Todd, David C ^a   Cockcroft, Donald W ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FORMOTEROL; MONTELUKAST; PREDNISONE; SALBUTAMOL SULFATE; STEROID; THEOPHYLLINE;

ADULT; ASTHMA; AVASCULAR NECROSIS; CASE REPORT; CATARACT; CELLULITIS; CHURG STRAUSS SYNDROME; DISEASE EXACERBATION; HOSPITALIZATION; HUMAN; LETTER; MALE; OSTEOPOROSIS; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; RECURRENT INFECTION; SIDE EFFECT; STRIA; SURVIVAL; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VERTEBRA FRACTURE; WEIGHT GAIN;

EID: 1642495885     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61718-8     Document Type: Letter

References (2)

1. Vemuri P, Greenberger PA, Patterson R. Churg-Strauss syndrome: survival for 26 years. Ann Allergy Asthma Immunol. 2002;88:640-643.
2. Masi A, Hunter J. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome. Arthritis Rheum. 1990;33:1094-1110.